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1. Introduction 
The enzyme which catalyzes the following reaction: 
UDP-GalNAc + Gal..... + GalNaal + Gal + (UDP) 
2 2 
I I 
Fuccul Fucclll 
was previously shown to occur in the soluble form in 
human milk from donors with A or AB blood type 
and is under control of the A gene [ 1,2] . The A 
enzyme (N-acetyl-D-galactosaminyltransferase) has 
been found also in the human submaxillary glands 
[3] and gastric mucosa [4] . 
The B enzyme (ol-D-galactosyltransferase) catalyzes 
a reaction identical to that catalyzed by the A enzyme 
except galactose is transferred in place of N-acetyl- 
galactosamine [5]. The B enzyme is present in milk 
from donors or B of AB blood type and is absent in 
milk from donors with A or 0 blood type [5]. The 
occurrence of A and B enzymes in human milk are 
independent of secretor status of donors. The B 
enzyme has also been found in gastric mucosa and 
submaxillary glands of human and baboon [6,7]. 
This communication describes the occurrence of 
A and B enzyme in human plasma from individuals of 
A and B blood type respectively. Both enzymes occur 
in plasma of donors with AB blood type and are 
absent in plasma from individuals of 0 blood type. 
* This work was performed uring T.S.‘s stay as a Visiting 
Fellow in the Laboratory of Biochemical Pharmacology, 
National Institute of Arthritis and Metabolic Diseases, 
National Institutes of Health, Bethesda, Md. 20014, USA. 
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2. Materials and methods 
UDP-N-acetyl-D-galactosamine labeled with 14C in 
the acetyl group (5.0 mCi/mM) and UDP-Galactose 
(Galactose-UL-14C), (3 1 mCi/mM) were obtained from 
the International Chemical and Nuclear Corporation 
(Irvine, California). 2’-Fucosyllactose and Lacto-N- 
fucopentaose-I-COOH with structure**: 
Fuc 
(Xl 
2 
Ga~l-3GlcNAc@1-3GaIp14Glc-COOH 
(LNF-I-COOH) 
were kindly provided by Dr. A. Kobata. The blood 
type of the donors was determined on samples of 
blood by Mrs. Mary McGinniss of the blood bank of 
the National Institutes of Health. Blood was collected 
using citric acid as anticoagulant. Plasma was prepared 
freshly for each experiment. The amount of plasma 
protein used for the assays varied from 0.14 mg to 1 
mg per sample. Protein concentration was estimated, 
using a value of 7.3 g/100 ml as a theoretical concen- 
tration of protein in human plasma. 
A simple method for assaying A and B enzyme, 
devised by Kobata [8] was adopted here. 
The incubation mixture for the A enzyme assay 
contained: 0.005 mole UDPGalNAc (7 X lo4 cpm), 
** Abbreviations: 
GalNAc = N-acetyl-Dgalactosamine 
GlcNAc = N-acetyl-Dglucosamine 
Gal = D-galactose 
Fuc = L-fucose 
GIG = D-glucose 
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0.05 pmole LNF-I-COOH, 1 I.tmole MnCl, , 1.5 
mole Tris buffer pH 7.5 and plasma in a total volume 
of 85 /.d. 
The incubation mixture for the B enzyme assay 
contained: 0.015 mole UDPGal(9 X lo4 cpm), 0.05 
lrmole LNF-I-COOH, 0.2 pmole MnCL, 1.5 E.tmole 
Tris buffer pH 7.5 and plasma in a total volume of 85 
/Jl. 
One drop of toluene was added and the mixtures 
incubated at 37” for 16 hr. 
The solutions were’ transferred to Whatman No. 3 
MM paper as 3 cm band and subjected to electro- 
phoresis in pyridine/acetic acid buffer pH 5.4 [9] for 
110 min at 50 V/cm in a high voltage lectrophorator 
(Gilson Medical Electronics, Middleton, Wisconsin). 
The section of the chromatogram containing the 
product was localized using LNF-I-COOH as standard 
stained with benzidine reagent [lo] . 
Chromatograms were scanned for radioactivity using 
Vanguard automatic hromatogram scanner. Areas 
containing radioactive product were cut out and counted 
in 5 ml Bray’s solution [ 111 in a scintillation counter. 
Background of ’ 4C activity was determined from the 
corresponding area of another chromatogram derived 
from an incubation mixture in which LNF-I-COOH 
was omitted. 
3. Results and discussion 
Table 1 summarizes the distribution of the A and 
B enzymes in human plasma. In washed and hemolysed 
human erythrocytes no A enzyme activity was found. 
However, some B enzyme activity was present in 
hemolysed erythrocytes. Under the experimental 
condition described here no B enzyme activity was 
detected in serum, whereas A enzyme was detected. 
One, from various possible xplanations of this pheno- 
menon may be that proteins of B enzyme coagulate 
during clot formation. The results presented in table 2 
show that 2’-fucosyllactose can also serve as acceptor 
for both glycosyltransferases t ted. 
Glycosyltransferases of human plasma have pro- 
perties imilar to those described for human milk. This 
seems very likely, as milk enzymes are derived from 
plasma. The physiological role of glycosyltransferases 
occurring in human plasma is so far unknown. 
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Table 1 
Distribution of A enzyme (UDPGalNAc: galactose o <-3-N-acetylgalactosaminyltransferase) nd B enzyme (UDPGal: galactose 
o <-3-galactosyltransferase) in human plasma using LNF-I-COOH as acceptor. 
Donor Blood ABO Secretor status 
Sugar transferred to LNF-I-GOGH 
N-Acetylgahtctosamine 14C Galactose 14C 
F.S. 
E.R. 
B.H. 
A.W. 
E.K. 
C.Q. 
MC. G. 
J.H. 
A 
A 
B 
B 
AB 
AB 
0 
0 
Secretor 
Secretor 
Secretor 
Secretor 
Secretor 
Non secretor 
Non secretor 
Secretor 
cpmll6 hr/mg of protein 
879 
300 
10 
3 
230 
242 
15 
30 
0 
22 
153 
286 
233 
188 
25 
14 
Assay conditions as reported in sect. 2. 
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Table 2 
N-Acetylgalactosaminyltransferase and galactosyltransferase 
activity of human plasma using 2’-fucosyllactose as an acceptor. 
Donor 
Blood 
Sugar transferred to 2’-fucosyllactose 
ABO N-Acetylgalactosamine 14C Galactose 14C 
cpmll6 hr/mg of protein 
F.S. A 1160 
B.H. B - 350 
Mc.G. 0 0 0 
- = not tested. 
Assay conditions as reported under Materials and methods 
except that 0.5 pmole of 2’-fucosyllactose was used as acceptor 
in place of LNF-I-COOH. Products were isolated and charac- 
terized by paper chromatography according to methods 
described by Kobata, Grollmann and Ginsburg [ 1,5]. 
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